Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05531526 |
|---|---|
| Brief Title: | Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD) |
| First Submitted : | August 31, 2022 |
| First Submitted that Met QC Criteria : | September 2, 2022 |
| First Posted : | September 8, 2022 |
| Last Update Submitted that Met QC Criteria : | March 20, 2024 |
| Last Update Posted : | March 22, 2024 |